1Yang W,Lu J,Weng J. Prevalence of diabetes among men and women in China[J].{H}New England Journal of Medicine,2010,(12):1090-1101.
2Stratton IM,Adler AI,Neil HA. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes(UKPDS 35):prospective observational study[J].{H}BMJ:British Medical Journal,2000,(7258):405-412.
3Nathan DM,Cleary PA,Backlund JY. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes[J].{H}New England Journal of Medicine,2005,(25):2643-2653.
4Qian L,Xu L,Wang X. Early insulin secretion failure leads to diabetes in Chinese subjects with impaired glucose regulation[J].{H}Diabetes/Metabolism Research and Reviews,2009,(02):144-149.
8Jacobsen LV,S(φ)gaard B,Riis A. Pharmacokinetics and pharmacodynamics of a premixed formulation of soluble and protamine-retarded insulin aspart[J].{H}EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY,2000,(05):399-403.
9Warrant ML,Conway MJ,Klaff LJ. Postprandial versus preprandial dosing of biphasic insulin aspart in elderly type 2 diabetes patients[J].{H}Diabetes Research and Clinical Practice,2004,(01):23-29.
10Rosenfalck AM,Thorsby P,Kjems L. Improved postprandial glycaemic control with insulin Aspart in type 2 diabetic patients treated with insulin[J].{H}ACTA DIABETOLOGICA,2000,(01):41-46.
2Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med, 2010, 362: 1090-1101.
3Qian L, Xu L, Wang X, et al. Early insulin secretion failure leads to diabetes in Chinese subjects with impaired glucose reg- ulation. Diabetes Metab Res Rev, 2009, 25: 144-149.
4Home PD, Lindholm A, Riis A. Insulin aspart vs. human in- sulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial. Diabet Med 2000, 17: 762-770.
5Lindholm A, McEwen J, Riis AP. Improved postprandial gly- cemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes. Diabetes Care, 1999, 22: 801-805.
6Rosenfalck AM, Thorsby P, Kjems L, et al. Improved post- prandial glycaemic control with insulin Aspart in type 2 diabetic patients treated with insulin. Acta Diabetol, 2000, 37: 41-46.
7Raskin P, Allen E, Hollander P, et al. Initiating insulin thera- py in type 2 Diabetes: a comparison of biphasic and basal insu- lin analogs. Diabetes Care, 2005, 28: 260-265.
8Yang W, Gao Y, Liu G, et al. Biphasic insulin aspart 30 as in- sulin initiation or replacement therapy: the China cohort of the IMPROVE study. Curr Med Res Opin, 2010, 26: 101-107.
9Boehm BO, Home PD, Behrend C, et al. Premixed insulin as part 30 vs. premixed human insulin 30/70 twice daily: a ran- domized trial in type 1 and type 2 diabetic patients. Diabet Med 2002, 19: 393-399.
10Khutsoane D, Sharrna SK, Almustafa M, et al. Biphasic insu- lin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study. Diabetes Obes Metab, 2008, 10:212-222.
8DROUIN P, BLICKLE JF, CHARBONNEL B, et al. Diagnosis and classification of diabetes melliuts: the new eriteria[J]. Oiabetes Metab, 1999,25 (1) = 72- 83.
9YANG WY,LU JM,WENG JP,et al.Prevalence of Diabetes among Men and Women in China[J].N Engl J Med,2010,362 (12) :1090-1100.
10OWENS DR, LUZlO SD, SERT-LANGERON C, et al.Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month 'proof-of-concept' study [J]. Diabetes Obes Metab,2011,13(11):1020-1027.
